Legal & General Group’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $8.07K | Hold |
|
|||||
|
2024
Q4 | $9.6K | Sell |
|
|||||
|
2024
Q3 | $160K | Hold |
|
|||||
|
2024
Q2 | $168K | Sell |
|
|||||
|
2024
Q1 | $275K | Buy |
|
|||||
|
2023
Q4 | $235K | Hold |
|
|||||
|
2023
Q3 | $178K | Buy |
|
|||||
|
2023
Q2 | $355K | Buy |
|
|||||
|
2023
Q1 | $37.6K | Hold |
|
|||||
|
2022
Q4 | $55.8K | Hold |
|
|||||
|
2022
Q3 | $117K | Buy |
|
|||||
|
2022
Q2 | $95K | Buy |
|
|||||
|
2022
Q1 | $72K | Buy |
|
|||||
|
2021
Q4 | $17K | Hold |
|
|||||
|
2021
Q3 | $33K | Buy |
|
|||||
|
2021
Q2 | $8K | Buy |
|